With all this amazing great Science potential , BTD,  publications on several indications , I am going out  on limb that most like several  BP have a strong interest  to buyout or partner with RVX, but not near the premium that RVX is asking until they get a  successful trial either on Covid on Betonmace2  . just guessing......,    IDK but i would think a CVR type of deal , with milestone and endpoints we  would have by now,....a  win win  for both one would think